In Brief
Wasting is a process characterized by an involuntary loss of body mass observed under diverse conditions, including cancers. Kwon et al. demonstrate that localized Yorkie-induced overproliferation causes systemic organ wasting via the secreted insulin/IGF antagonist ImpL2. These findings establish a model for systemic organ wasting in adult Drosophila.
INTRODUCTION
Wasting is the process characterized by an involuntary loss of body mass manifested in particular by degeneration of skeletal muscles and adipose tissues. Wasting is not only a physiological condition responding to extremely low energy intake and infection but also part of a complex systemic disorder associated with many diseases, including cancers, chronic obstructive lung disease, congestive heart failure, chronic kidney disease, and other chronic diseases (Deboer, 2009; Delano and Moldawer, 2006; Planté -Bordeneuve and Said, 2011; Tisdale, 1997) . In particular, 50% of advanced cancer patients are affected by wasting syndrome, which accounts for approximately 20% of cancer death (Fearon et al., 2013; Penna et al., 2010) . A number of studies have implicated proinflammatory cytokines, such as tumor necrosis factor a and interleukin 1 and 6, as secreted factors involved in wasting associated with various conditions (Fearon et al., 2013; Kir et al., 2014; Penna et al., 2010; Tisdale, 2009 ). Additionally, insulin-like growth factor 1 (IGF-1) signaling is a critical regulator of muscle mass maintenance Rommel et al., 2001; Sandri et al., 2004) . Downregulation of IGF-1 signaling in skeletal muscles decreases Akt activity and in turn increases Foxo activity, which induces muscle protein degradation through the ubiquitin-proteasome system and autophagy (Han et al., 2013) . Moreover, the transforming growth factor b family members myostatin and activin have been identified as additional secreted factors regulating organ wasting (Fearon et al., 2012; Han et al., 2013) . Stimulation of myostatin/activin signaling in skeletal muscles activates Smad2/3 signaling and inhibits Akt signaling, which increases catabolism of muscle proteins (Fearon et al., 2012; Han et al., 2013) .
The ''bloating syndrome,'' observed in flies transplanted with imaginal discs mutant for the tumor suppressor lethal (2) giant larvae (l(2)gl) (Gateff and Schneiderman, 1974) , is a systemic phenotype relevant to the wasting syndrome. Whereas a wildtype imaginal disc transplanted into the abdomen of an adult fly only grows until it reaches its normal size, a transplanted l(2) gl mutant disc undergoes neoplastic growth and eventually kills the fly. However, before they die, these flies develop the bloating syndrome, whereby the abdomen becomes swollen and translucent and the fat body and ovaries are almost completely degenerated (Gateff and Schneiderman, 1974) . This degeneration of the fat body and ovaries is reminiscent of the wasting of adipose tissue and skeletal muscles in mammals, because the fat body and ovaries are the organs preserving energy in the forms of lipids and proteins in Drosophila. Strikingly, although the bloating syndrome is a robust phenotype, it has not been characterized in detail. In particular, it is not known whether the wasting process affects metabolism and how neoplastic l(2)gl mutant discs induce degeneration of ovaries and the fat body.
The transcriptional coactivator yorkie (yki) regulates growth, repair, and regeneration by inducing a transcriptional program required for cell proliferation and survival (Halder and Johnson, 2011; Harvey and Hariharan, 2012; Pan, 2010; Staley and Irvine, 2012; Yang and Xu, 2011) . In particular, studies in adult Drosophila have identified a crucial role of yki in the regulation of intestinal stem cell (ISC) proliferation during tissue homeostasis and damage (Karpowicz et al., 2010; Ren et al., 2010; Shaw et al., 2010) . Furthermore, these studies have shown that activation of Yki in the midgut induces massive cell proliferation, which conceivably affects the physiology of the proliferating tissue as well as the homeostasis of distant tissues and the whole organism. However, it is not known whether and how localized cell proliferation in the midgut driven by activation of Yki perturbs the physiology and function of distant organs and the whole organism.
Here we show that induction of aberrant cell proliferation in the midgut by activation of Yki causes the bloating syndrome, which is associated with degeneration of the ovary, fat body, and muscle. We characterize in detail the systemic wasting phenotypes associated with the proliferating midgut using genomic, metabolomic, and physiological analyses. Finally, we show that the secreted insulin/IGF antagonist ImpL2 is involved in the wasting process by decreasing systemic insulin/IGF signaling.
RESULTS

Localized Aberrant Cell Proliferation Induced by Activation of Yki in ISCs Causes Systemic Organ Wasting
To address how localized aberrant cell proliferation alters organismal homeostasis, we expressed an active form of yki (yki act ) (Oh and Irvine, 2009) in adult midgut ISCs using the conditional GAL4 driver esg ts (esg-GAL4, tub-GAL80 ts , UAS-GFP/+) (hereafter referred to as esg ts >yki act ). Consistent with the proposed role of yki in the midgut (Karpowicz et al., 2010; Ren et al., 2010; Shaw et al., 2010) , expression of yki act resulted in massive cell proliferation as detected by an increase in GFP signal and aberrant shape of the gut ( Figure 1A) . Strikingly, over time, these flies developed the bloating syndrome phenotype ( Figures 1B and B 0 ), originally described in adult flies with transplanted imaginal discs harboring a mutation in the tumor suppressor l(2)gl in the abdomen (Gateff and Schneiderman, 1974) . esg ts >yki act flies exhibit this bloating phenotype as early as 5 days after induction of yki act . Both the penetrance and severity of the phenotype progressively increase, with $70% of flies showing the phenotype at 6 days ( Figure 1B ) and $95% at 12 days ( Figure 1B 0 ). Additionally, ovaries and fat bodies of esg ts >yki act females degenerate progressively with time ( Figures 1C and 1D ). In adult flies, the fat body does not form as a discrete structure but fills the abdominal space, resulting in a continuous light yellow mass. Whereas fat bodies in controls were not affected ( Figures 1B and 1D ), the fat bodies in esg ts >yki act flies were observed as discontinuous patches at 6 days (Figures 1B and 1D 0 ) and were almost completely degenerated at 12 days of yki act induction (Figure 1B 0 ; magnified images are not shown). Furthermore, we observed accelerated decline of muscle function in esg ts >yki act flies. esg ts >yki act flies showed progressive climbing defects ( Figure 1E ) and downturned wings ( Figure 1F ), general indicators of muscle weakening/degeneration (Demontis and Perrimon, 2010; Greene et al., 2003) . To characterize the underlying cellular defects associated with muscle weakening/degeneration in esg ts >yki act , we examined the structures of esg ts >yki act muscles by electron microscopy. Mitochondria of esg ts >yki act muscles were swollen and often associated with empty space ( Figure 1G ). Moreover, cristae were fragmented, and inner mitochondrial space was filled with low-electron-dense sectors ( Figure 1G 0 ), indicative of mitochondrial degeneration (Greene et al., 2003) . Altogether, these findings reveal that aberrant cell proliferation induced by activation of Yki in ISCs causes systemic organ-wasting phenotypes affecting ovaries, fat body, and muscle.
Expression of yki act in Midgut Causes Repression of Genes Involved in Energy Metabolism in Muscle
To gain insight into the systemic phenotypes induced by esg ts >yki act , we performed a transcriptomic analysis of thoracic muscles (Table S1 ), which play an important role in the regulation (Tables S2 and S3 ). Node size indicates enrichment (Àlog 100 p value), and edge thickness represents the number of common genes between two gene sets. The citric acid cycle and pyruvate metabolism (p = 0.0253, GSEA) and oxidative phosphorylation (p = 0.000, GSEA) are identified by GSEA analysis (Subramanian et al., 2005) . (B) Representative downregulated processes and complexes involved in energy metabolism. Heat map signal indicates log 2 fold-change values relative to the mean expression level within the group. Red signal denotes higher expression and green signal denotes lower expression relative to the mean expression level within the group. Related GSEA plots are shown in Figure S1 .
(legend continued on next page) of organismal physiology and aging by affecting systemic insulin/IGF signaling and trehalose/glucose metabolism (Demontis and Perrimon, 2010) . Interestingly, gene list enrichment analysis of the downregulated muscle transcriptome revealed a striking enrichment of multiple metabolic processes impinging on carbohydrate metabolism (p = 0.0018), amino acid metabolism (p = 1.32 3 10 À7 ), metabolism of vitamins and cofactors (p = 1.32 3 10 À7 ), and metabolism of xenobiotics by cytochrome P450 (p = 1.45 3 10 À4 ) (Figure 2A ; Tables S2 and S3 ). Furthermore, we found a systematic repression of genes involved in energy metabolism (p = 0.000, gene set enrichment analysis; GSEA), including glycolysis (p = 0.018, GSEA), pyruvate metabolism and the citric acid cycle (p = 0.0252, GSEA), and oxidative phosphorylation (p = 0.000, GSEA) (Figures 2A and 2B; Figure S1 ; Table S4 ). We further confirmed by quantitative (q)PCR that the expression of multiple genes involved in glycolysis was decreased not only in muscles but also in ovaries of esg ts >yki act flies ( Figures 2C and 2D ). Moreover, the activities of the two ratelimiting glycolytic enzymes Hexokinase (Hex-A and Hex-C) and Phosphofructokinase (Pfk) are reduced by approximately 30% in esg ts >yki act muscle ( Figure 2E ). Accordingly, ATP levels in muscles were significantly decreased in esg ts >yki act flies as compared to controls ( Figure 2F ). Moreover, metabolomic analyses revealed a decrease of ATP, NADH, and NADPH levels in the hemolymph of esg ts >yki act flies ( Figure 2G ; Figure S2 ; Table S5 ), which are the main products of energy metabolism. Altogether, these results suggest that esg ts >yki act alters the metabolic gene expression program of distant tissues, which is manifested by downregulation of genes involved in glycolysis in muscle and ovaries.
Overproliferating Midgut due to Activation of Yki Causes Hyperglycemia Because we observed that gene expression of glycolytic enzymes in muscles and ovaries was downregulated in esg ts >yki act flies, we investigated whether there were any changes in glucose metabolism in these flies. As expected from the bloating phenotype, the volume of extractable hemolymph from esg ts >yki act flies was greatly increased as compared to controls ( Figure 3A) . Nevertheless, the concentration of trehalose, the primary circulating sugar composed of two alpha-glucoses, was significantly increased in the hemolymph of esg ts >yki act flies ( Figure 3B ). Accordingly, whole-body trehalose levels were increased in esg ts >yki act flies ( Figure 3C ). Additionally, consistent with the degeneration of the fat body that stores triglycerides and glycogen in the adult, whole-body triglycerides and glycogen levels were reduced in esg ts >yki act flies, as compared to controls ( Figures 3D and 3E ).
Starvation causes a reduction in whole-body trehalose levels ( Figure S3B ), suggesting that the increase of trehalose levels in esg ts >yki act flies is not due to the effect of starvation (Figures 3B and 3C) . Nevertheless, starvation affects storage of triglycerides and glycogen (Figures S3C and S3D) . Thus, because the presence of cell overproliferation in the midgut could in principle perturb gut functions and mimic starvation, we addressed whether esg ts >yki act altered food intake and absorption. Measurements of food intake and excretion did not appear to be significantly affected in esg ts >yki act flies ( Figures  3F and 3G ). To further test whether esg ts >yki act flies are starved, we examined Drosophila insulin-like peptide 2 (Dilp2) levels in Dilp-producing cells (IPCs) in the brain, because starvation causes accumulation of Dilp2, presumably due to a reduction in secretion (Demontis and Perrimon, 2010; Gé minard et al., 2009; Ikeya et al., 2002) . Surprisingly, the Dilp2 signal in the IPCs of esg ts >yki act flies was significantly decreased (Figures 3H and 3I) . This decrease of Dilp2 signal is not due to a reduction in Dilp2 mRNA, as we observed that the levels of Dilp mRNAs in the heads remained unaffected in esg ts >yki act flies ( Figure 3J ). Moreover, we tested a starvation marker, Pepck, which is regulated by both sugar and glycine (Zinke et al., 1999) , and found that Pepck mRNA expression was increased $50-fold during starvation ( Figure S3F ). Conversely, Pepck mRNA expression remained unaltered at 6 days of yki act induction and increased $3-fold at 12 days ( Figure S3F ), suggesting that esg ts >yki act flies were not severely starved. Altogether, these findings indicate that aberrant cell proliferation, induced by activation of yki, causes systemic abnormality in trehalose/glucose metabolism, which resembles hyperglycemia. Further, because Dilp2 is not accumulated in the IPCs and Pepck expression is not greatly affected, it is unlikely that starvation is the main cause of the phenotypes associated with esg ts >yki act . However, we cannot rule out that other aspects of gut function are perturbed, contributing to the organ-wasting and bloating phenotypes (see Discussion).
Depletion of ImpL2 from esg ts >yki act Midguts Rescues Systemic Reduction of Akt1 Phosphorylation and Hyperglycemia To identify the signaling factor(s) impinging on systemic phenotypes in esg ts >yki act flies, we interrogated the muscle transcriptome of esg ts >yki act . Interestingly, target genes of Foxo, a transcription factor inhibited by insulin/IGF signaling, are enriched in the upregulated muscle transcriptome of esg ts >yki act flies (p = 0.039; Figure 4A ). In particular, Thor (human 4E-BP ortholog), a well-characterized target of Foxo, is significantly upregulated ( Figure 4B ). Consistent with the transcriptome analysis results, Akt phosphorylation is significantly reduced in muscles and heads of esg ts >yki act flies ( Figure 4C ). To characterize the mechanism by which esg ts >yki act reduces systemic insulin/IGF signaling, we examined whether the expression of ImpL2, a secreted protein that resembles IGFBP7 (Sloth Andersen et al., 2000) and that inhibits insulin/IGF signaling by forming (C and D) Relative mRNA expression of glycolytic enzyme in muscle (C) and ovaries (D). Measurements shown are mean ± SDs. (E) Activities of Hexokinase (left) and Pyruvate kinase (right) in muscle at 8 days of induction (mean ± SEMs). (F) ATP levels in muscle at 20 days of transgene induction. (G) Metabolomic analysis of hemolymph metabolites. The metabolite counts are normalized to fly number (black) or extracted hemolymph volume (gray). Log 2 fold-change values of the metabolites in hemolymph of esg ts >yki act flies relative to control are presented. Reduced 55 metabolites in hemolymph of esg ts >yki act flies are shown in Figure S2 . *p % 0.05 (Student's t test) compared to control. Genotypes are as shown in Figure 1 . a protein complex with circulating Dilps (Alic et al., 2011; Honegger et al., 2008) , was affected in esg ts >yki act flies. Strikingly, ImpL2 mRNA expression was greatly elevated in esg ts >yki act midguts at 6 days of yki act induction, whereas the expression of ImpL2 remained unchanged in muscles, ovaries, heads, and fat bodies ( Figure 4D ). Interestingly, starvation regulates ImpL2 expression (Honegger et al., 2008) , and we further confirmed that starvation increased ImpL2 mRNA expression in heads, muscles, midguts, and fat bodies ( Figure S3E ). The absence of ImpL2 mRNA induction in the muscles, ovaries, heads, and fat bodies of esg ts >yki act flies further supports that these flies are not calorie deprived. Moreover, ImpL2 mRNA expression is increased $70-fold in the esg ts >yki act midgut, which appears to greatly exceed the range of induction during starvation ( Figure 4D ; Figure S3E ).
To address the role of ImpL2, we examined whether removal of ImpL2 activity could rescue the systemic phenotypes associated with esg ts >yki act . The null allele ImpL2 Def20 (Honegger et al., 2008) completely rescued the reduction of Akt1 phosphorylation in esg ts >yki act flies ( Figure 4C ) and restored circulating trehalose concentration and whole-body trehalose levels (Figures S4A and S4B) . The rescue of the systemic phenotypes associated with esg ts >yki act by ImpL2 Def20 is presumably due to a systemic increase of insulin/IGF signaling, as ImpL2 Def20 alone caused a slight increase of Akt1 phosphorylation ( Figure 4C ) and reduction of circulating trehalose concentration ( Figure S4A ). Next, to examine the importance of ImpL2 induction in the midgut, we coexpressed an RNAi against ImpL2 (15009R-3) together with yki act . The expression of ImpL2-RNAi efficiently suppressed the induction of ImpL2 in esg ts >yki act midgut ($80% knockdown efficiency), although the expression of ImpL2 remained 8-fold higher than in controls ( Figure S4C ). Notably, expression of ImpL2-RNAi alone using esg ts did not significantly alter Akt1 phosphorylation and trehalose levels (Figures 4C, 4E, and 4F) . Importantly, knockdown of ImpL2 with esg ts restored Akt1 phosphorylation in muscles and heads significantly ( Figure 4C ) and reduced the trehalose levels ( Figures 4E and 4F ). This rescue is not due to suppression of cell proliferation, because the overall shape and GFP intensity of esg ts >yki act midguts remained unaltered after ImpL2-RNAi expression ( Figure 4G ). Additionally, similar experiments employing an additional ImpL2-RNAi line (30931) further confirmed the importance of ImpL2 induction in the midgut for the systemic phenotypes associated with esg ts >yki act (Figures S4D-S4F ). In addition, ectopic expression of ImpL2 in enterocytes (ECs) in the midgut caused hyperglycemia, reduction of Akt1 phosphorylation in muscle, increase of hemolymph volume, and ovary atrophy ( Figures S4G-S4K ), suggesting that the increased ImpL2 expression was sufficient to cause some of the systemic phenotypes associated with esg ts >yki act . Altogether, our results indicate that induction of ImpL2 in esg ts >yki act midguts is a critical determinant for both the hyperglycemia and systemic reduction of insulin/IGF signaling in esg ts >yki act flies. Depletion of ImpL2 in esg ts >yki act Midguts Rescues Ovary Wasting and Muscle Degeneration Next, we addressed whether ImpL2 is involved in the organwasting process associated with esg ts >yki act . Interestingly, either ImpL2 def20 or depletion of ImpL2 in the midgut with esg ts suppressed wasting of ovaries caused by esg ts >yki act (Figure 5A ). In addition, expression of ImpL2 in the midgut is required for the muscle degeneration observed in esg ts >yki act flies. Depletion of ImpL2 in the midgut with esg ts rescued the climbing defects and downturned wings in esg ts >yki act flies ( Figures 1E, 1F , 5B, and 5C). Strikingly, expression of ImpL2-RNAi with esg ts was sufficient to significantly rescue the mitochondrial defects ( Figures 1G, 1G 0 , 5D, and 5D 0 ) and reduced ATP levels ( Figures  2F and 5E ). Finally, we found that the bloating phenotype in esg ts >yki act flies was also dependent on ImpL2, because knockdown of ImpL2 in the midgut with esg ts significantly rescued the bloating phenotype ( Figure 5F ). Altogether, these results indicate that degeneration of ovaries and muscle in esg ts >yki act flies is dependent on increased expression of ImpL2 in the midgut.
Expression of Insulin/IGF Pathway Components and Glycolytic Enzymes Is Upregulated in the Proliferating Midgut due to Aberrant Activation of Yki
Although insulin/IGF signaling is indispensable for yki act -mediated cell proliferation in the midgut (data not shown), esg ts >yki act midguts undergo cell proliferation irrespective of the induction of ImpL2. Strikingly, instead of observing a reduction of Akt1 phosphorylation, expression of yki act increased the levels of both pAkt1 and Akt1 in the midgut (Figures 6A and  6B ), similar to a previous observation in the wing disc (Ye et al., 2012) . Moreover, overall Akt1 phosphorylation in the midgut was greatly increased as compared to control ( Figure S5 ). Interestingly, we found that gene expression of insulin/IGF pathway components was systematically increased . The values shown are mean ± SEMs. The asterisk denotes statistically significant difference from control (adjusted p = 1.239 3 10 À87 ; p values are adjusted with the Benjamini-Hochberg procedure, which controls the false discovery rate; Benjamini and Hochberg, 1995) . (G) Midgut morphology. GFP is driven by esg ts and UAS-GFP. Nuclei are marked with 4 0 ,6-diamidino-2-phenylindole (DAPI) (blue). The arrows indicate the posterior end of the midgut. The genotype of control is esg-GAL4, tub-GAL80 ts , UAS-GFP/+, yki act is esg-GAL4, tub-GAL80 ts , UAS-GFP/+; UAS-yki act /+, yki act , ImpL2 Def20 is esg-GAL4, tub-GAL80 ts , UAS-GFP/+; UAS-yki act , ImpL2 Def20 /ImpL2 Def20 , 15009R-3 is esg-GAL4, tub-GAL80 ts , UAS-GFP/15009R-3 (UAS-ImpL2 RNAi from the National Institute of Genetics, Japan), 15009R-3; yki act is esg-GAL4, tub-GAL80 ts , UAS-GFP/15009R-3; UAS-yki act /+, and ImpL2 Def20 is esg-GAL4, tub-GAL80 ts , UAS-GFP/+; ImpL2 Def20 /ImpL2 Def20 .
in esg ts >yki act midgut (InR, $8-fold; Akt1, $12-fold; Figure 6C ). Conversely, the mRNA levels of these genes were not affected significantly in muscles and ovaries, with the exception of InR in muscles ( Figure S6 ). Finally, expression of yki act in the midgut elevated the transcript of Dilp3, which regulates insulin/IGF signaling in that tissue (O'Brien et al., 2011) (Figure 6D ). Thus, our findings suggest that expression of yki act in the midgut causes a disparity in the activity of insulin/IGF signaling between the midgut and other tissues. Interestingly, extracellular signalregulated kinase activation was shown to enhance insulin/ IGF signaling by increasing the expression of InR transcript (Zhang et al., 2011) . Additionally, ras V12 ; csk À/À transformed cells increased InR expression through Wingless signaling to evade the insulin resistance induced by a high-sugar diet (Hirabayashi et al., 2013) . Although Foxo is a well-characterized transcription factor regulating InR expression (Puig and Tjian, 2005) , these observations and ours suggest that some mitogenic signals can enhance insulin/IGF signaling by increasing InR expression.
This disparity of insulin/IGF signaling activities presumably leads to differential regulation of glucose metabolism between the midgut and other tissues. In contrast to the observations in muscles and ovaries ( Figures 2C and 2D) , the mRNA expression of glycolytic enzymes was systematically increased in esg ts >yki act midguts ( Figure 6E ). In particular, the mRNA levels of two key rate-limiting enzymes, Hex-A and Pfk, were increased by $4and $10-fold, respectively, and the ortholog of lactate dehydrogenase, ImpL3, which is a major contributor to the Warburg effect (Vander Heiden et al., 2009; Warburg, 1956) , was increased $7-fold. Consistent with overproliferation in the midgut, we observed increased glucose incorporation in esg ts >yki act midgut as compared to controls ( Figure 6F ). Strikingly, in other parts of these flies, glucose incorporation was reduced by $50% (Figure 6F ), a process dependent on wild-type ImpL2 allele, because ImpL2 def20 rescued the reduction of glucose incorporation in the whole-body void of midgut and hemolymph induced by esg ts >yki act (Figure 6F ). Altogether, these observations suggest that activation of yki in the midgut causes a bias in glucose metabolism between the midgut and other tissues, and that ImpL2 is a genetic determinant of this phenomenon.
DISCUSSION
In this study, we describe the unexpected observation that the overproliferating midgut due to aberrant Yki activity in ISCs induces the bloating syndrome and systemic organ wasting. Additionally, the overproliferating midgut perturbs organismal metabolism, resulting in an increase of hemolymph trehalose and depletion of glycogen and triglyceride storage (Figure 7) . Strikingly, we show that the accumulation of hemolymph trehalose and organ-wasting processes are dependent on the antagonist of insulin/IGF signaling, ImpL2, which is specifically upregulated in the proliferating midgut. Our study provides strong genetic evidence supporting that systemic organ wasting associated with the aberrant activation of Yki in ISCs cannot be explained solely by the perturbation of general gut function. Based on these findings, we propose that ImpL2 is a critical factor involved in systemic organ wasting in Drosophila.
In an accompanying paper in this issue of Developmental Cell, Figueroa-Clarevega and Bilder show that transplantation of scrib 1 /Ras V12 disc tumors into wild-type flies induces the bloating syndrome phenotype and systemic organ wasting, affecting ovaries, fat bodies, and muscles (Figueroa-Clarevega and Bilder, 2015) . Figueroa-Clarevega and Bilder also identify ImpL2 as a tumor-driven factor that plays a critical role in the organ-wasting process. These results are consistent with our findings and indicate that the bloating syndrome and organ-wasting phenotypes are not associated specifically with perturbation of gut function. Interestingly, Figueroa-Clarevega and Bilder observe that disc tumors derived by the expression of yki S/A (an active form of yki that is less potent than yki act used in this study) did not cause organ wasting, which can be explained by the low level of ImpL2 induction in the yki S/A tumors as compared to scrib 1 / Ras V12 tumors.
Our results do not rule out the existence of an additional factor(s) contributing to the bloating syndrome and organwasting phenotypes. Indeed, the partial rescue of the bloating syndrome and organ-wasting phenotypes by depletion of ImpL2 in esg ts >yki act midguts suggests the existence of an additional factor(s). Moreover, we observed that ectopic expression of ImpL2 in ECs was not sufficient to reduce whole-body triglyceride and glycogen levels (data not shown), although it caused hyperglycemia, reduction of Akt1 phosphorylation, and increase of hemolymph volume (Figures S4G-S4J) . Thus, given the involvement of diverse factors in the wasting process in mammals, it is likely that in addition to ImpL2, another factor(s) contributes to systemic organ wasting in Drosophila.
Our study shows that the bloating syndrome caused by esg ts >yki act is associated with ImpL2, as depletion of ImpL2 from esg ts >yki act midguts significantly rescues the bloating phenotype. Given the observation that elevated expression of ImpL2 from esg ts >yki act midgut induces hyperglycemia, we speculate that the accumulation of trehalose in hemolymph is a factor involved in bloating, because a high concentration of trehalose can cause water influx to adjust hemolymph osmolarity to physiological levels. Interestingly, recent findings have shown that disruption of l(2)gl in discs activates yki (Grzeschik et al., 2010; Halder and Johnson, 2011; Mené ndez et al., 2010; Staley and Irvine, 2012) , suggesting that the bloating syndrome observed in flies with transplanted l(2)gl mutant discs may be due to aberrant yki activity.
Our findings are reminiscent of a previous study showing that in Drosophila, humoral infection with the bacterial pathogen Mycobacterium marinum, which is closely related to Mycobacterium tuberculosis, causes a progressive loss of energy stores in the form of fat and glycogen-a wasting-like phenotype (Dionne et al., 2006) . Similar to our observation, Dionne et al. found that infection with M. marinum caused a downregulation of Akt1 phosphorylation. Given our observation that ImpL2 produced from esg ts >yki act affects systemic insulin/IGF signaling, it will be of interest to test whether ImpL2 expression is increased upon infection with M. marinum and mediates the effect on the loss of fat and glycogen storage.
yki plays critical roles in tissue growth, repair, and regeneration by inducing cell proliferation (Johnson and Halder, 2014; Pan, 2010; Staley and Irvine, 2012) , a process requiring additional nutrients to support rapid synthesis of macromolecules including lipids, proteins, and nucleotides. In particular, increased aerobic glycolysis metabolizing glucose into lactate is a characteristic feature of many cancerous and normal proliferating cells (Vander Heiden et al., 2011) . Interestingly, the aberrant activation of yki in ISCs caused a disparity in the gene expression of glycolytic enzymes and the activity of insulin/IGF signaling between the proliferating midgut and other tissues, such as muscle and ovaries (Figure 7) . Thus, we speculate that this disparity favors Yki-induced cell proliferation by increasing the availability of trehalose/glucose to the proliferating midgut, which presumably requires high levels of trehalose/glucose (Figure 7) . Additionally, it will be of interest to test whether activation of Yki during tissue growth, repair, and regeneration alters systemic metabolism in a similar manner.
EXPERIMENTAL PROCEDURES
Fly Stocks and Manipulation of Midgut Progenitor Cells UAS-yki act (w*;; UAS-yki.S111A.S168A.S250A.V5; 228817) (Oh and Irvine, 2009 ) was obtained from the Bloomington Drosophila Stock Center. esg ts refers to tub-GAL80 ts , esg-GAL4, UAS-GFP (II) (Apidianakis et al., 2009) . RNAi line 15009R-3 against ImpL2 was obtained from the National Institute of Genetics, Japan. 30931 is an RNAi line against ImpL2 obtained from the Vienna Drosophila Resource Center, Austria. RNAi lines obtained from the Transgenic RNAi Project (http://www.flyrnai.org) are JF01482 (InR), JF01987 (Pten), and HM04007 (Akt1). Additionally, we used UAS-Pten (III), UAS-myr-Akt1 (III), and ImpL2 Def20 (gift from Hugo Stocker).
To induce transgenes in midgut stem cells, we followed the experimental procedures described previously (Apidianakis et al., 2009 ). Briefly, crosses were set up with esg ts at room temperature, and after 3 days of incubation at room temperature were transferred to 18 C to activate GAL80 ts , thus restricting the expression of the Gal4-induced transgenes. Zero-to 4-dayold adult progenies were collected and placed at 29 C to induce the transgenes. Progenies from a cross between esg ts and w 1118 were used as controls. During incubation at 29 C, flies were transferred onto fresh food every 2 days.
Measurement of Carbohydrate and Triglyceride Levels
We measured fly carbohydrates and triglycerides as described previously (Song et al., 2010 (Song et al., , 2014 Teleman et al., 2005) . To prepare fly lysates for metabolic assays, we homogenized six female adults from each group in 400 ml PBS supplemented with 0.2% Triton X-100, heated the homogenate at 70 C for 5 min, and collected the supernatant after centrifugation at 14,000 rpm for 10 min. Whole-body trehalose levels were measured from 10 ml of supernatant treated with 0.2 ml trehalase (Megazyme; E-TREH) at 37 C for 30 min using glucose assay reagent (Megazyme; K-GLUC) following the manufacturer's protocol. We subtracted the amount of free glucose from the measurement and then normalized the subtracted values to protein levels in the supernatant. Whole-body glycogen levels were determined from 10 ml of supernatant preincubated with 1 ml amyloglucosidase (Sigma-Aldrich; A7420) at 37 C for 30 min using glucose assay reagent (Megazyme; K-GLUC). Free glucose levels were subtracted from the measurements, and glycogen levels were normalized to total protein levels. To measure whole-body triglycerides, we processed 10 ml of supernatant using a Serum Triglyceride Determination kit (Sigma-Aldrich; TR0100). We subtracted the amount of free glycerol in the supernatant from the measurement and then normalized the subtracted values to protein levels in the supernatant.
To measure circulating trehalose concentrations, hemolymph was extracted from 10-20 decapitated female adults by centrifugation at 1,500 3 g for 15 min. Half a microliter of the collected hemolymph was diluted in 40 ml of TBS buffer (5 mM Tris-HCl [pH 6.6], 137 mM NaCl, 2.7 mM KCl), heated at 70 C for 5 min, and centrifuged at 14,000 rpm for 10 min. The supernatant was treated with 0.2 ml trehalase (Megazyme; E-TREH) at 37 C for 30 min and then used to measure circulating trehalose levels with glucose assay reagent (Megazyme; K-GLUC). We subtracted the amount of free glucose in the supernatant from the measurement.
Hemolymph volumes were measured using either a micropipette P2.5 (Eppendorf) or P10 (Gilson) and normalized to the number of flies used for hemolymph extraction.
Glucose Incorporation Assay
Fifteen to 25 flies incubated at 29 C for 3 days were transferred onto fresh food with 2 mCi [U-14 C]glucose (PerkinElmer; NEC042V). After 2 days of incubation at 29 C, the flies were transferred again onto fresh food with 2 mCi [U-14 C]glucose and incubated for an additional 2 days. To remove the food in the gut, we placed the flies onto nonradioactive food for 7-8 hr prior to dissection. Then, seven midguts were dissected in PBS and collected in 250 ml RIPA buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% sodium deoxycholate, 1 mM EDTA, 0.1% SDS, 1% NP-40) after rinsing them twice with PBS. To collect the whole-body void of midgut and hemolymph, we dissected out the midguts through a small incision in the abdomen. Dissected flies were placed in an Eppendorf tube with 1 ml PBS and then washed four times with 1 ml PBS by inverting three to five times. Three dissected flies were homogenized in 250 ml RIPA buffer. After homogenization, we added 300 ml water to the homogenates to increase the volume. Five hundred microliters of homogenate was mixed with 10 ml Ultima Gold liquid scintillation cocktail (PerkinElmer; 6013326) in 20-ml glass scintillation vials. Disintegrations per minute values were measured and normalized to control.
RNA Sequencing Analysis of Muscle Transcriptome
To extract total RNAs for RNA sequencing (RNA-seq) experiments, we used ten thoraces dissected out from flies incubated for 8 days at 29 C. After assessing RNA quality with an Agilent Bioanalyzer, mRNAs were enriched by poly(A) pull-down. Then, sequencing libraries constructed with an Illumina TruSeq RNA preparation kit were sequenced using an Illumina HiSeq 2000 at the Columbia Genome Center (http://systemsbiology.columbia. edu/genome-center). We multiplexed samples in each lane, which yields a targeted number of single-end 100-bp reads for each sample, as a fraction of 180 million reads for the whole lane. Sequence reads were mapped back to the Drosophila genome (FlyBase genome annotation version r5.51) using TopHat (Trapnell et al., 2009) . With the uniquely mapped reads, we quantified gene expression levels using Cufflinks (Trapnell et al., 2012) (fragments per kb of exon per million fragments mapped values). Next, we performed data normalization on the read counts and applied a negative binomial statistical framework using the Bioconductor package DESeq to quantify differential expression between experimental and control data. The RNA-seq data were deposited in the Gene Expression Omnibus (accession number GSE65325).
Metabolomics of Hemolymph Metabolites
To collect hemolymph, thoraces of approximately 200 flies were pierced with a tungsten needle. Next, the flies were placed in a perforated 0.5-ml Eppendorf tube within a 1.5-ml Eppendorf tube and then centrifuged twice at 2,348 3 g for 4 min at 4 C with a gentle mixing of the flies between centrifugations. Collected hemolymph was centrifuged again at 2,348 3 g for 3 min to precipitate hemocytes and other debris. The supernatant was centrifuged at 14,000 3 g for 15 min to remove the insoluble fraction. Processed hemolymph was flashfrozen on dry ice and kept at À80 C until metabolomic sample preparation.
Metabolomic samples were prepared essentially as described previously (Yuan et al., 2012) . Briefly, a hemolymph sample was diluted in À80 C methanol for a final methanol concentration of 80%. Then, the sample was briefly vortexed and stored at À80 C overnight. The sample was then centrifuged at 14,000 3 g for 10 min. The supernatant was dried in a SpeedVac and then frozen at À80 C. For liquid chromatography-tandem mass spectrometry (LC-MS/MS), the resuspended sample in 20 ml of LC-MS-grade water was centrifuged and 10 ml was injected. Mass spectrometry was performed as described previously (Yuan et al., 2012) at the Beth Israel Deaconess Medical Center Mass Spectrometry Facility (http://www.bidmcmassspec.org). Briefly, selected reaction monitoring of 287 Q1/Q3 transitions was targeted in positive/ negative switching mode using a 5500 QTRAP hybrid triple quadrupole mass spectrometer (AB SCIEX). Amide HILIC chromatography (Waters) was used at high pH over a 20-min gradient. Integrated peak area values of each metabolite were normalized to hemolymph volume or fly number.
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